Your cofounder has a stroke at 38.
She survives. The doctors say she'll recover most motor function. She'll walk again. She'll talk again. But the cognitive demands of running a venture-backed startup as CEO — the 14-hour days, the context-switching across engineering, fundraising, sales, and board management, the constant high-stakes decision-making under pressure — that's over. Permanently.
She's alive. She's your friend. She's also the person who owns 40% of your company and can never contribute to it again.
Death is devastating, but it's clear. The person is gone. Their equity enters their estate. Insurance pays out. A buy-sell agreement triggers. There's a process. Disability is none of those things. Disability is ambiguous, emotional, and legally complicated in ways that destroy startups from the inside.
The equity problem nobody talks about
When a founder dies, their equity transfers to their estate and can be repurchased through a buy-sell agreement funded by life insurance. The math is hard but the process is straightforward.
When a founder becomes permanently disabled, they still own their shares. They're still on the cap table. They may still have a board seat, voting rights, information rights, and veto provisions depending on your corporate documents.
The equity deadlock
Your disabled cofounder owns 40% of the company. She can't work, but she can vote. Her shares are fully vested. She needs income — medical bills are $15K/month and climbing. She wants the company to buy her out, but the company's 409A valuation puts her shares at $3.2M. You have $1.8M in the bank and 11 months of runway.
She can't afford to wait. You can't afford to pay. Neither of you wants to sue the other. But without a mechanism to resolve this, the only options are: she sells her shares to a third party (who becomes your new cofounder whether you like it or not), or this ends up in court.
Your investors are watching. Your employees are anxious. Your company is paralyzed.
The vesting complication
If your cofounder's shares are fully vested — which they are at most startups past year four — there's no clawback mechanism. The company can't take equity back just because someone can't work. Without a specific disability provision in your shareholder agreement or buy-sell agreement, the disabled founder's equity position is permanent and untouchable.
Even if shares aren't fully vested, most standard vesting agreements don't address disability directly. Vesting typically terminates when employment terminates — but if the disabled founder is still technically an officer of the company, the vesting question gets complicated fast.
The "still a shareholder" problem
Your disabled cofounder retains all shareholder rights. That means they receive financial reports. They get notified of major corporate actions. They may need to sign off on new financing rounds, asset sales, or changes to the company's certificate of incorporation.
If cognitive impairment is part of the disability, their legal capacity to make those decisions may be questioned — but the company can't just ignore their rights. You may need a court-appointed conservator or power of attorney to act on their behalf, which introduces more lawyers, more time, and more cost.
The operational gap
Everything that applies when a cofounder dies applies when they become disabled — the knowledge loss, the investor anxiety, the team retention problem. But disability adds a unique complication: there's no closure.
With death, the team grieves and moves forward. With disability, the team exists in limbo. Is she coming back? Should we wait? Should we hire a replacement? If we hire someone, what happens if she recovers partially? What's her role then? Every question has ten sub-questions, and none of them have clean answers.
The operational paralysis is real. Decisions get delayed because no one knows whether to plan for the founder's return or their permanent absence. Strategic initiatives stall. Hiring freezes. The company runs in maintenance mode while the founding team's future is uncertain.
The emotional complexity
This is the part nobody prepares you for. Your cofounder is alive. They're your friend. You've built this company together for five years. Now you're in a situation where protecting the company might mean buying them out of the thing they helped create — and doing it at a time when they're at their most vulnerable.
Without pre-agreed terms, this conversation is brutal. You're essentially telling a disabled friend that you need their equity back. No matter how rational the business case, it feels like betrayal. And the disabled founder, dealing with their own fear and grief, may not see it as a business decision at all.
This is exactly why these agreements need to exist before anything happens. When everyone is healthy and the discussion is theoretical, you can negotiate fair, empathetic terms. When someone is in a hospital bed, every conversation is loaded.
How a disability buy-sell trigger works
A properly structured buy-sell agreement includes disability as a trigger event — alongside death, voluntary departure, and termination for cause. Here's how it works:
Defining "disability"
The agreement defines disability precisely — typically as the inability to perform the material duties of the founder's role for a continuous period (usually 90 or 180 days) as certified by a qualified physician. This eliminates ambiguity. Either the founder meets the definition or they don't.
The buyout mechanism
Once the disability trigger is met, the buy-sell agreement obligates the company (or the remaining founders) to purchase the disabled founder's equity at a pre-agreed valuation. The disabled founder is required to sell. This isn't optional for either side — it's a binding obligation established when everyone was healthy and thinking clearly.
The valuation method
Valuation is determined by whatever method the agreement specifies — usually the most recent 409A valuation, a formula based on revenue multiples, or an independent appraisal. The key is that it's decided in advance, not negotiated under duress.
The payment timeline
Most disability buyouts allow for structured payments over 12-36 months, rather than a lump sum. This protects the company's cash position while ensuring the disabled founder receives fair value for their equity. Insurance proceeds can accelerate this timeline significantly.
Funding the buyout with disability insurance
A buy-sell agreement with a disability trigger is a promise. Disability buy-sell insurance is the money that backs that promise.
Here's how the funding works: the company purchases disability buy-sell insurance on each founder. If a founder becomes disabled and the buy-sell triggers, the insurance pays out a lump sum (or structured payments) that the company uses to buy the disabled founder's equity.
The protected scenario
Your cofounder has a stroke. After 180 days, it's clear she won't return to her CEO role. The disability trigger in your buy-sell agreement activates. The company's disability buy-sell insurance begins paying out — $3.2M structured over 24 months, matching the 409A valuation of her shares.
Your cofounder receives fair value for the equity she helped build. She can focus on recovery without financial stress. The company reclaims the shares and redistributes them to attract a new CEO-caliber leader. Investors see a company that planned for the worst. The team sees founders who treated each other with fairness and foresight.
Nobody is happy about what happened. But nobody is destroyed by it, either.
Key man disability insurance
Separate from the buy-sell funding, key man disability insurance covers the operational costs of losing a founder to disability — the same way key man life insurance covers the costs associated with death. This funds recruitment, retention bonuses, interim leadership, and extended runway while the company transitions.
What most founders get wrong
Most founders who have any protection at all have life insurance through a key man policy. Far fewer have disability coverage. This is backwards.
The risk of disability is significantly higher than the risk of death for founders in their 20s, 30s, and 40s. Strokes, traumatic brain injuries, severe autoimmune conditions, mental health crises — these happen to young, healthy people. The startup lifestyle of chronic stress, poor sleep, and delayed healthcare makes founders more vulnerable, not less.
If you have key man life insurance but no disability coverage, you've insured against the less likely event and left the more likely one completely unprotected.
Build the protection before you need it
Disability protection for founders requires three components working together:
- A buy-sell agreement with a disability trigger: Defines what happens to equity, at what valuation, on what timeline
- Disability buy-sell insurance: Funds the equity buyout so the company doesn't have to choose between fair treatment and survival
- Key man disability insurance: Covers the operational costs of losing a founder — recruitment, retention, interim leadership
These aren't three separate projects. They're one conversation with the right advisor, structured in a few weeks, and maintained as part of your regular corporate governance.
If you haven't had this conversation yet, book a 15-minute intro call. We'll walk through your current agreements, identify the gaps, and build a plan that protects both the company and your cofounders. No jargon. No pressure. Just clarity on a risk most founders ignore until it's too late.
Coverage subject to underwriting approval. Insurance products vary by state. Consult your tax and legal advisors for situation-specific guidance.